Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 12 points (0.1%) at 17,830 as of Tuesday, Nov. 25, 2014, 12:15 PM ET. The NYSE advances/declines ratio sits at 1,420 issues advancing vs. 1,510 declining with 216 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is unchanged.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Becton Dickinson ( BDX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Becton Dickinson is up $2.68 (2.0%) to $133.79 on average volume. Thus far, 769,189 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $131.03-$134.06 after having opened the day at $131.03 as compared to the previous trading day's close of $131.11.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $25.0 billion and is part of the health care sector. Shares are up 18.7% year-to-date as of the close of trading on Monday. Currently there are 6 analysts who rate Becton Dickinson a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Becton Dickinson Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, WellPoint ( WLP) is up $0.92 (0.7%) to $127.06 on light volume. Thus far, 379,030 shares of WellPoint exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $126.27-$127.58 after having opened the day at $126.57 as compared to the previous trading day's close of $126.14.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $34.0 billion and is part of the health care sector. Shares are up 36.5% year-to-date as of the close of trading on Monday. Currently there are 7 analysts who rate WellPoint a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.87 (0.9%) to $97.77 on light volume. Thus far, 1.1 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 3.9 million shares. The stock has ranged in price between $96.91-$97.85 after having opened the day at $97.12 as compared to the previous trading day's close of $96.90.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $92.8 billion and is part of the health care sector. Shares are up 28.7% year-to-date as of the close of trading on Monday. Currently there are 15 analysts who rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null